Current Report Filing (8-k)
October 22 2021 - 4:47PM
Edgar (US Regulatory)
false 0001865537 0001865537 2021-10-22 2021-10-22 0001865537 dtrt:ClassACommonStockAndWarrantsMemberMember 2021-10-22 2021-10-22 0001865537 us-gaap:CommonClassAMember 2021-10-22 2021-10-22 0001865537 dtrt:WarrantMemberMember 2021-10-22 2021-10-22
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): October 22, 2021
DTRT HEALTH ACQUISITION CORP.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
001-40774
|
|
86-3336784
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
1415 West 22nd Street, Tower Floor
Oak Brook, IL 60523
(Address of principal executive offices, including zip code)
Registrant’s telephone number, including area code (312) 316-5473
Not Applicable
(Former name or former address, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
|
|
|
|
|
Title of each class
|
|
Trading
Symbol(s)
|
|
Name of each exchange
on which registered
|
Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant
|
|
DTRTU
|
|
The Nasdaq Stock Market LLC
|
Class A common stock, par value $0.0001 per share
|
|
DTRT
|
|
The Nasdaq Stock Market LLC
|
Redeemable warrants, each warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share
|
|
DTRTW
|
|
The Nasdaq Stock Market LLC
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
On October 22, 2021, DTRT Health Acquisition Corp. (the “Company”) announced that the holders of the Company’s units (the “Units”) may elect to separately trade the shares of Class A common stock, par value $0.0001 per share (the “Class A Common Stock”), and warrants (the “Warrants”) included in the Units commencing on October 25, 2021. Each Unit consists of one share of Class A Common Stock and one-half of one Warrant to purchase one share of Class A Common Stock. Any Units not separated will continue to trade on The Nasdaq Capital Market (the “Nasdaq”) under the symbol “DTRTU.” Any underlying shares of Class A Common Stock and Warrants that are separated are expected to trade on the Nasdaq under the symbols “DTRT” and “DTRTW,” respectively. No fractional Warrants will be issued upon separation of the Units and only whole Warrants will trade. Holders of Units will need to have their brokers contact Continental Stock Transfer & Trust Company, the Company’s transfer agent, in order to separate the holders’ Units into shares of Class A Common Stock and Warrants.
A copy of the press release issued by the Company announcing the separate trading of the securities underlying the Units is attached as Exhibit 99.1.
Item 9.01
|
Financial Statements and Exhibits.
|
(d) Exhibits
EXHIBIT INDEX
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
DTRT HEALTH ACQUISITION CORP.
|
|
|
By:
|
|
/s/ Mark Heaney
|
|
|
Name:
|
|
Mark Heaney
|
|
|
Title:
|
|
Chief Executive Officer
|
Dated: October 22, 2021
DTRT Health Acquisition (NASDAQ:DTRTU)
Historical Stock Chart
From May 2024 to Jun 2024
DTRT Health Acquisition (NASDAQ:DTRTU)
Historical Stock Chart
From Jun 2023 to Jun 2024